PR Newswire Biotechnology

Biotechnology news and information from @PRNewswire. Some paid tweets may appear.

[PR Newswire Biotechnology @PRNBiotech]

We've Moved! Please follow us @PRN_TopStories for popular and trending press releases from @PRNewswire.

Don't miss out!

#pressrelease #topstories #PR

[PR Newswire Biotechnology @PRNBiotech]

#RDHL’s #opaganib selected by the #USgovernment’s @ASPRgov @BARDA for joint development & funding as a medical #countermeasure to treat exposure to #Ebola virus disease. $RDHL PR: https://t.co/uz7DAbmC7i

[PR Newswire Biotechnology @PRNBiotech]

As the WHO declared monkeypox outbreak as a public health emergency of international concern, Fapon Biotech reaffirms its commitment by providing antigen diagnostic solutions addressing this threat. https://t.co/7yrKxBc4IJ

[PR Newswire Biotechnology @PRNBiotech]

Fapon, a global leading life sciences company, is showcasing its innovative IVD total solutions at ADLM 2024. Committed to supporting local partners, Fapon delivers customized solutions with innovations and localization services. https://t.co/8XWDfyHzpR

[PR Newswire Biotechnology @PRNBiotech]

Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-stage Cancer.
https://t.co/DtesOBvEDR
See more on @PRNewswire!

[PR Newswire Biotechnology @PRNBiotech]

LifeSpan Vision Ventures Invests in Matter Bio.
https://t.co/8Y8RwXLnTP
See more on @PRNewswire!

[PR Newswire Biotechnology @PRNBiotech]

Human Microbiome Market size worth USD 1,689.5 Million, Globally, by 2027 at 21.8% CAGR: Verified Market Research®. See more on @PRNewswire!
https://t.co/uBEvueormA

[PR Newswire Biotechnology @PRNBiotech]

https://t.co/UEwhFsvi0s

[PR Newswire Biotechnology @PRNBiotech]

AI-based wastewater sampling predicts COVID pressure on hospitals. See more on @PRNewswire!
https://t.co/zncCndxNoz
#AI #COVID

[PR Newswire Biotechnology @PRNBiotech]

Combined Therapeutics to Present Multi-Organ Protection (MOP) mRNA Vaccine Platform at the 3rd mRNA-Based Therapeutics Summit. Read more on @PRNewswire! cc: @TheTXAttorney 
https://t.co/K3hq9TZw9t

[PR Newswire Biotechnology @PRNBiotech]

Metagenomic Sequencing Market worth $4.5 Billion | MarketsandMarkets. Read more on @PRNewswire! cc: @marketsmarkets 
https://t.co/2cwju1RCho

[PR Newswire Biotechnology @PRNBiotech]

Join thousands of subscribers by signing up for our free weekly newsletter: https://t.co/63InBRZ7ma

Get all the top stories from @PRNewswire sent directly to your inbox every Friday. Sign up today!!

#PRNewswire #topstories

[PR Newswire @PRNewswire]

Too busy to follow all the big headlines sent via PR Newswire? New PRN Newsletters will bring the top stories, subjects and industries you care about directly to your inbox.

Sign up today: https://t.co/tbRLQjjyiM

[PR Newswire Biotechnology @PRNBiotech]

PRN Newsletters bring the top stories to you. Sign up today to get PRN’s top stories and curated news delivered to your inbox weekly: https://t.co/093qWFX3xg

[PR Newswire Biotechnology @PRNBiotech]

Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine. Read more on @PRNewswire! cc: @googlecloud 

https://t.co/IOUyz6sdy4
#AI #googlecloud

[PR Newswire Biotechnology @PRNBiotech]

FDA Roundup: Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Read more on @PRNewswire! cc: @US_FDA 
https://t.co/Ck9Dbbu61t
#FDA

[PR Newswire Biotechnology @PRNBiotech]

Micron Biomedical Announces Positive Measles and Rubella Vaccination Results from First Clinical Trial of Microarray Injection-Free Vaccine Delivery in Children. Read more on @PRNewswire!
https://t.co/lMAf0ihQta
#vaccines

[PR Newswire Biotechnology @PRNBiotech]

Zymo Research launches full-length 16S sequencing service to revolutionize microbiome research. Read more on @PRNewswire! cc: @ZymoResearch 
https://t.co/aHH6yA2Ltt
#microbiomics

[PR Newswire Biotechnology @PRNBiotech]

Synthego Opens State-of-the-Art GMP Guide RNA Manufacturing Facility to Enable CRISPR Genomic Medicines. Read more on @PRNewswire! cc: @Synthego 
https://t.co/5m4Fs7ah3T
#crispr

[PR Newswire Biotechnology @PRNBiotech]

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease. Read more on @PRNewswire! cc: @US_FDA 
https://t.co/t6I5BLOvDj
#alzheimers #fda